Navigation Links
Study finds language barriers may play role in health care disparities
Date:9/28/2010

(Boston) - Researchers from Boston Medical Center (BMC) and Boston University School of Public Health (BUSPH) have found that individuals who do not speak English at home are less likely to receive colorectal cancer screenings (CRC) as compared to those who do speak English at home. The findings, which currently appear on-line in the Journal of General Internal Medicine, suggest that patient-provider language barriers play a role in health-care disparities, and that providers should promote the importance of CRC screening to non-English speaking patients.

The United States has tremendous ethnic and linguistic diversity. According to the 2005� American Community Survey, minorities comprise 26 percent of the population, and nearly 20 percent of Americans speak a language other than English at home. By 2050, it is projected that minorities will comprise about half of the US population, with a similar increase in individuals speaking a language other than English at home.

The researchers performed a retrospective study of individuals age 50 years and older who were categorized as English-concordant (spoke English at home); other Language-Concordant (did not speak English at home but someone at their provider's office spoke their language); or other Language-Discordant (did not speak English at home and no one at their provider's spoke their language). Compared to English speakers, non-English speakers had lower rates of CRC screening. Compared to the English-Concordant group, the Other Language-Discordant group had similar screening levels, while the Other Language-Concordant group had lower screening levels.

"Our initial findings are consistent with other reports. However, in our adjusted model, we found that those who did not speak English at home but who had someone at their provider's office who spoke their preferred language, had the lowest rate of CRC screening and this was unexpected," said lead author Amy Linsky, MD, a fellow in general internal medicine at BMC.

"Our results suggest that providers should especially promote the importance of CRC screenings to non-English speaking patients, but that patient-provider language barriers do not fully account for lower CRC screening in patients who do not speak English at home," added co-investigator Nathalie McIntosh, a doctoral student in health Policy and Management at BUSPH.

According to the researchers, these findings may be related to unmeasured differences between the two cohorts, including patient characteristics, provider cultural competence, patient acculturation, the quality of patient-provider communication, and the level of patient health literacy including obtaining colorectal cancer screening. "Professional interpreters and language-concordant providers may be necessary, but not sufficient to mitigate these disparities," added Linsky.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related biology news :

1. First study of its kind finds children with food allergies are often victims of bullying
2. Wiecha receives grant to study face-to-face vs. virtual health education for African-American women
3. National study: Abortion does not cause depression or low self-esteem in adolescents
4. BUSM researchers to study vitamin D production in fat malabsorption patients
5. Arctic soil study turns up surprising results
6. Study links normal function of protein, not its build up inside cells, to death of neurons
7. Study offers first explanation of how cells rapidly repair and maintain structure
8. Gene-environmental interactions and MS progression is focus of new study
9. Manganese in drinking water: Study suggests adverse effects on childrens intellectual abilities
10. Women with diabetes having more C-sections and fetal complications: study
11. Study finds possible persistence switch for tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Cancer experts from Austria, Hungary, Switzerland, and ... new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just published ... , Biomarkers are components in the blood, tissue or body fluids that ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... , ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension ... are higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... bottom of the cuvette holder. , FireflySci has developed several Agilent flow cell ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: